Novo Nordisk Boosts Profit Outlook Novo Nordisk raised profit guidance. Weight-loss drugs exceeded expectations. Q1 sales up 32% to 96.8 billion kroner. Operating profit up 65% to 59.6 billion kroner. Sales outperformed analyst forecast. Operating profit surpassed expectations. Sales | Profit | Pharma Denmark 2 weeks ago